BofA Finance LLC has filed a pricing supplement for its Capped Buffered Enhanced Return Notes, which are linked to the MSCI EAFE Index. This filing, dated November 12, 2026, is significant as it showcases the company’s strategy to enhance its product offerings within the national commercial banking sector.
The Capped Buffered Enhanced Return Notes are expected to price on November 12, 2026, and are set to issue on November 17, 2026. This financial instrument is designed to provide investors with exposure to the performance of the MSCI EAFE Index while offering certain protections against market volatility.
Background
BofA Finance LLC, classified under the SIC code 6021 for National Commercial Banks, is based in Charlotte, North Carolina. The company is a subsidiary of Bank of America Corporation, which also operates under the same SIC classification. The recent filing is part of a series of filings made by the company, including several other pricing supplements filed on November 13, 2026.
What the Filing Says
The filing states, "The Capped Buffered Enhanced Return Notes Linked to the MSCI EAFE Index, due November 16, 2028, are expected to price on November 12, 2026 and expected to issue on November 17, 2026." This indicates a structured investment product aimed at providing a specific return based on the underlying index's performance.
Impact
This new offering may attract a range of investors looking for innovative investment solutions, particularly those interested in equity-linked notes. The guarantee from Bank of America Corporation adds a layer of security for potential investors, which may influence their decision-making process.
What's Next
The filing does not specify what happens next, but it indicates that the pricing and issuance of the notes will occur shortly after the filing date.
Read Next
Dominion Energy announces $1.2 billion senior notes issuance
Lakefront Biotherapeutics Launches €50 Million Share Buyback
Coca-Cola Europacific Partners Announces Share Buyback Details
Zenta Group announces $6.47 million at-the-market offering
MapLight Therapeutics Enters $100 Million Sales Agreement
Cyabra, Inc. Secures $15.6 Million in Private Placement










